Administrative and Biostatistics Core
行政和生物统计核心
基本信息
- 批准号:10629066
- 负责人:
- 金额:$ 22.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-06 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdoptedBioinformaticsBiometryBiostatistics CoreCancer EtiologyCessation of lifeCollaborationsCommunicationCommunitiesDataData AnalysesData AnalyticsData SetData Storage and RetrievalDecision MakingDepositionDisparateEnsureEpigenetic ProcessExhibitsExperimental DesignsFacultyFoundationsFutureGoalsHeterogeneityInformation TechnologyLeadLeadershipMalignant NeoplasmsMalignant neoplasm of pancreasMetabolicMethodsMonitorPancreatic Ductal AdenocarcinomaPatientsReagentRecommendationReportingReproducibilityResearchResearch Project GrantsResource SharingResourcesRiskServicesSignal PathwaySystemWorkcost effectivedata exchangedata integrationdata sharingexperimental studymeetingsmembernew therapeutic targetnovelorganizational structureprogramspublic repositoryresponsesuccesstherapy resistanttumor
项目摘要
PROJECT SUMMARY – Administrative and Biostatistics Core
The overall goal of the Administrative and Biostatistics Core (Admin Core) is to facilitate research efforts toward
understanding intrinsic resistance to therapy in pancreatic ductal adenocarcinoma (PDA). This will be
accomplished by providing the three Research Projects (Projects) and the three Shared Resource Cores (Cores)
with organizational support, professional project management, biostatistical expertise, data storage and sharing
solutions, and a governance framework. The Admin Core will plan and coordinate meetings between the
scientific teams, as well as between the scientific teams and the leadership groups. The Admin Core will include
a Project Manager, who will provide professional project management services to ensure that stated objectives
are successfully achieved. As part of this effort, the Project Manager will monitor Core activities to ensure that
efforts of these cutting-edge scientific resources are integrated and coordinated, and that the Cores are operating
effectively and efficiently to meet the needs of the Projects. The Project Manager will also establish a governance
framework for resolving potential conflicts between team members and for managing resource utilization and
budgetary concerns. The Admin Core will include a Biostatistics Unit that will be intimately involved in all
experimental design and data analysis. The Biostatistics Unit will be responsible for ensuring that all experiments
are sufficiently powered, and that the resulting data are analyzed using the most scientifically rigorous
approaches. Novel methods will be developed when needed. One faculty-level statistician will split their effort
between the Biostatics Unit and the bioinformatics team within the Tumor and Microenvironment
Heterogeneity Core, coordinating communication and the transfer of data between these data analytic groups.
Finally, the Admin Core will include a Data Curator who will help establish and oversee a centralized data-storage
system into which all data generated by the scientific teams will be deposited and properly annotated. This
resource will facilitate the integration of disparate datasets, as well as the exchange of data and reagents
between the Projects, the Cores, and the external research community, as appropriate. Thus, the specific aims
of the Admin Core are to: 1) provide overall organizational support including the coordination of meetings
between the Projects, the Cores, and the leadership committees, 2) provide project management services to
ensure that scientific objectives are achieved in an efficient and cost-effective manner, 3) provide biostatistical
expertise to ensure experimental rigor and reproducibility, and 4) create and manage a centralized data storage
and sharing system to enable data integration.
项目摘要 - 行政和生物统计核心
行政和生物统计核心(Admin Core)的总体目标是促进研究工作
了解胰腺导管腺癌 (PDA) 治疗的内在耐药性。
通过提供三个研究项目(Projects)和三个共享资源核心(Cores)来完成
具有组织支持、专业项目管理、生物统计专业知识、数据存储和共享
解决方案和治理框架将规划和协调各部门之间的会议。
科学团队以及科学团队和领导小组之间将包括。
项目经理,将提供专业的项目管理服务,以确保既定目标的实现
作为这项工作的一部分,项目经理将监控核心活动,以确保
这些尖端科学努力的整合和协调,并且核心正在运行
有效且高效地满足项目的需求 项目经理还将建立治理。
解决团队成员之间潜在冲突和管理资源利用的框架
管理核心将包括一个生物统计部门,该部门将密切参与所有工作。
实验设计和数据分析。生物统计部门将负责确保所有实验。
动力充足,并且使用最科学严谨的方法对所得数据进行分析
需要时将开发新方法。一名教职级统计学家将分担他们的工作。
肿瘤和微环境内的生物统计学部门和生物信息学团队之间
异构核心,协调这些数据分析组之间的通信和数据传输。
最后,管理核心将包括一名数据管理员,他将帮助建立和监督集中式数据存储
科学团队生成的所有数据都将存储在该系统中并进行适当注释。
资源将促进不同数据集的整合以及数据和试剂的交换
项目、核心和外部研究团体之间的具体目标(视情况而定)。
管理核心的职责是: 1) 提供整体组织支持,包括协调会议
项目、核心和领导委员会之间的合作,2) 提供项目管理服务
确保以高效且具有成本效益的方式实现科学目标,3)提供生物统计
确保实验严谨性和可重复性的专业知识,以及 4) 创建和管理集中式数据存储
和共享系统以实现数据集成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TONY R. HUNTER其他文献
TONY R. HUNTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TONY R. HUNTER', 18)}}的其他基金
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
克服胰腺导管腺癌的治疗耐药机制
- 批准号:
10629062 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
项目 2:靶向信号网络克服胰腺癌的治疗耐药性
- 批准号:
10629064 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Histidine phosphorylation as a new target for cancer therapy
组氨酸磷酸化作为癌症治疗的新靶点
- 批准号:
10680390 - 财政年份:2019
- 资助金额:
$ 22.79万 - 项目类别:
Histidine phosphorylation as a new target for cancer therapy
组氨酸磷酸化作为癌症治疗的新靶点
- 批准号:
10228707 - 财政年份:2019
- 资助金额:
$ 22.79万 - 项目类别:
Histidine phosphorylation as a new target for cancer therapy
组氨酸磷酸化作为癌症治疗的新靶点
- 批准号:
10020348 - 财政年份:2019
- 资助金额:
$ 22.79万 - 项目类别:
Histidine phosphorylation as a new target for cancer therapy
组氨酸磷酸化作为癌症治疗的新靶点
- 批准号:
10450680 - 财政年份:2019
- 资助金额:
$ 22.79万 - 项目类别:
The Invisible Phosphoproteome: New Tools to Study Histidine Phosphorylation
看不见的磷酸化蛋白质组:研究组氨酸磷酸化的新工具
- 批准号:
9228357 - 财政年份:2015
- 资助金额:
$ 22.79万 - 项目类别:
The Invisible Phosphoproteome: New Tools to Study Histidine Phosphorylation
看不见的磷酸化蛋白质组:研究组氨酸磷酸化的新工具
- 批准号:
9437683 - 财政年份:2015
- 资助金额:
$ 22.79万 - 项目类别:
The Invisible Phosphoproteome: New Tools to Study Histidine Phosphorylation
看不见的磷酸化蛋白质组:研究组氨酸磷酸化的新工具
- 批准号:
9017975 - 财政年份:2015
- 资助金额:
$ 22.79万 - 项目类别:
相似国自然基金
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
开发和自动化基于细胞外囊泡的测试以早期检测肝细胞癌
- 批准号:
10823687 - 财政年份:2023
- 资助金额:
$ 22.79万 - 项目类别:
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
病毒多样性是改进艾滋病毒发病率估计的创新生物标志物
- 批准号:
10676203 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别: